These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 35711452)

  • 1. Low Memory T Cells Blood Counts and High Naïve Regulatory T Cells Percentage at Relapsing Remitting Multiple Sclerosis Diagnosis.
    Canto-Gomes J; Silva CS; Rb-Silva R; Boleixa D; da Silva AM; Cheynier R; Costa P; González-Suárez I; Correia-Neves M; Cerqueira JJ; Nobrega C
    Front Immunol; 2022; 13():901165. PubMed ID: 35711452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.
    Duszczyszyn DA; Beck JD; Antel J; Bar-Or A; Lapierre Y; Gadag V; Haegert DG
    Clin Exp Immunol; 2006 Feb; 143(2):305-13. PubMed ID: 16412055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. People with Primary Progressive Multiple Sclerosis Have a Lower Number of Central Memory T Cells and HLA-DR
    Canto-Gomes J; Da Silva-Ferreira S; Silva CS; Boleixa D; Martins da Silva A; González-Suárez I; Cerqueira JJ; Correia-Neves M; Nobrega C
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific alterations in NKG2D
    Carmena Moratalla A; Carpentier Solorio Y; Lemaître F; Farzam-Kia N; Da Cal S; Guimond JV; Haddad E; Duquette P; Girard JM; Prat A; Larochelle C; Arbour N
    Mult Scler Relat Disord; 2023 Mar; 71():104542. PubMed ID: 36716577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of EBV and HHV-6 Viral Load with Different NK and CD8
    Salehi Z; Beheshti M; Nomanpour B; Khosravani P; Naseri M; Sahraian MA; Izad M
    Cell J; 2021 Nov; 23(6):626-632. PubMed ID: 34939755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Subsets Characterization in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis.
    D'Amico E; Zanghì A; Parrinello NL; Romano A; Palumbo GA; Chisari CG; Toscano S; Raimondo FD; Zappia M; Patti F
    Front Immunol; 2022; 13():819136. PubMed ID: 35273601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis.
    Canto-Gomes J; Boleixa D; Teixeira C; Martins da Silva A; González-Suárez I; Cerqueira J; Correia-Neves M; Nobrega C
    Int Immunopharmacol; 2024 Apr; 131():111826. PubMed ID: 38461632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis.
    Hug A; Korporal M; Schröder I; Haas J; Glatz K; Storch-Hagenlocher B; Wildemann B
    J Immunol; 2003 Jul; 171(1):432-7. PubMed ID: 12817027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells.
    Tilly G; Cadoux M; Garcia A; Morille J; Wiertlewski S; Pecqueur C; Brouard S; Laplaud D; Degauque N
    Front Immunol; 2021; 12():730342. PubMed ID: 34721394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset.
    Puthenparampil M; Zito A; Pantano G; Federle L; Stropparo E; Miante S; De Silvestro G; Plebani M; Gallo P
    Mult Scler; 2019 Jun; 25(7):918-926. PubMed ID: 29882478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teriflunomide modulates both innate and adaptive immune capacities in multiple sclerosis.
    Wu Q; Wang Q; Yang J; Mills EA; Chilukuri P; Saad A; Dowling CA; Fisher C; Kirch B; Mao-Draayer Y
    Mult Scler Relat Disord; 2023 Jul; 75():104719. PubMed ID: 37172367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological profiles of HIV-positive recipients of liver transplant.
    Righi E; Ivaldi F; La Rosa A; Carnelutti A; Londero A; Bassetti M
    Transpl Immunol; 2019 Dec; 57():101208. PubMed ID: 31102654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8
    Benallegue N; Nicol B; Lasselin J; Bézie S; Flippe L; Regue H; Vimond N; Remy S; Garcia A; Le Frère F; Anegon I; Laplaud D; Guillonneau C
    Neurol Neuroimmunol Neuroinflamm; 2022 Nov; 9(6):. PubMed ID: 36266052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis.
    Gilmore W; Lund BT; Li P; Levy AM; Kelland EE; Akbari O; Groshen S; Cen SY; Pelletier D; Weiner LP; Javed A; Dunn JE; Traboulsee AL
    J Neuroinflammation; 2020 Jun; 17(1):189. PubMed ID: 32539719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
    Hjorth M; Dandu N; Mellergård J
    PLoS One; 2020; 15(2):e0228380. PubMed ID: 32012202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The frequencies of peripheral blood CD5
    Khani L; Jazayeri MH; Nedaeinia R; Bozorgmehr M; Nabavi SM; Ferns GA
    Allergy Asthma Clin Immunol; 2022 Jan; 18(1):5. PubMed ID: 35031055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells.
    Airas L; Saraste M; Rinta S; Elovaara I; Huang YH; Wiendl H;
    Clin Exp Immunol; 2008 Feb; 151(2):235-43. PubMed ID: 18062798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Percentage of CD8
    Houston TW; Howlett-Prieto Q; Regenauer C; Testai FD; Yao F; Feng X; Reder AT
    Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36535763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies.
    Boldt A; Borte S; Fricke S; Kentouche K; Emmrich F; Borte M; Kahlenberg F; Sack U
    Cytometry B Clin Cytom; 2014 May; 86(3):191-206. PubMed ID: 24488780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granzyme B + CD8 + T cells with terminal differentiated effector signature determine multiple sclerosis progression.
    Shi Z; Wang X; Wang J; Chen H; Du Q; Lang Y; Kong L; Luo W; Qiu Y; Zhang Y; Li C; Wen D; Yao J; Cheng X; Cai L; Lin X; Wang R; Mou Z; Li S; Liu D; Zhou H; Zhou H; Yang M
    J Neuroinflammation; 2023 Jun; 20(1):138. PubMed ID: 37268957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.